Table 9.

CSF findings and attack severity in patients with acute disease in group I (i.e., ≤ 14 days since onset of the neurological symptoms)

	Units	Severe/moderate	Mild
WCC, all	Cells/µl	2 (0–651;71)	2 (0–373;15)
WCC, elevated	Samples	10/62 (16.1%)	1/7 (14.3%)
OCB, pattern 1	Samples	26/80 (32.5%)	13/20 (65%)
OCB, pattern 4	Samples	50/80 (62.5%)	4/20 (20%)
Link index	Samples	1/65 (1.5%)	0/14 (0%)
QIgG, all	Ratio	4.3 (1–22.4;66)	2.9 (1.6–7.5;14)
QIgG, elevated	Samples	1/66 (1.5%)	0/14 (0%)
QAlb, all	Ratio	9.3 (3.2–50.8;66)	6.9 (3.6–29.9;15)
QAlb, elevated	Samples	39/66 (59.1%)	7/15 (46.7%)
QAlb, if elevated	Ratio	12.5 (6.8–50.8;39)	9.8 (6.7–29.9;7)
CSF TP, all	Mg/dl	49 (18.2–240.4;63)	42.2 (17.5–175;13)
CSF TP, elevated	Samples	35/63 (55.6%)	6/13 (46.2%)
CSF TP, if elevated	Mg/dl	70.1 (45.3–240.4;35)	54.7 (48.6–175;6)
CSF TP, > 100 mg/dl	Samples	11/90 (12.2%)	1/18 (5.6%)
CSF L-lactate, all	Mmol/l	2.1 (1.3–4;60)	1.7 (1.3–3.5;13)
CSF L-lactate, elevated	Samples	16/60 (26.7%)	4/13 (30.8%)
CSF L-lactate, if elevated	Mmol/l	3.1 (2.2–4;16)	2.8 (2.6–3.5;4)
CSF L-lactate, > 3 mmol/l	Samples	11/85 (12.9%)	2/18 (11.1%)

Results are given as medians (with ranges and sample or patient numbers in brackets) and frequencies (with percentages in brackets), respectively. OCB oligoclonal IgG bands, QAlb CSF/serum albumin quotient, QIgG CSF/serum IgG quotient; TP total protein, WCC white cell count